Assessing the potential of glucokinase activators in diabetes therapy
- 17 April 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 8 (5), 399-416
- https://doi.org/10.1038/nrd2850
Abstract
Glucokinase, a unique isoform of the hexokinase enzymes, which are known to phosphorylate D-glucose and other hexoses, was identified during the past three to four decades as a new, promising drug target for type 2 diabetes. Glucokinase serves as a glucose sensor of the insulin-producing pancreatic islet beta-cells, controls the conversion of glucose to glycogen in the liver and regulates hepatic glucose production. Guided by this fundamental knowledge, several glucokinase activators are now being developed, and have so far been shown to lower blood glucose in several animal models of type 2 diabetes and in initial trials in humans with the disease. Here, the scientific basis and current status of this new approach to diabetes therapy are discussed.Keywords
This publication has 131 references indexed in Scilit:
- Restoration of Hepatic Glucokinase Expression Corrects Hepatic Glucose Flux and Normalizes Plasma Glucose in Zucker Diabetic Fatty RatsDiabetes, 2009
- Glucose Sensing in L Cells: A Primary Cell StudyCell Metabolism, 2008
- Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose ConcentrationsDiabetes, 2008
- Molecular Physiology of Mammalian GlucokinaseCellular and Molecular Life Sciences, 2008
- The Common P446L Polymorphism in GCKR Inversely Modulates Fasting Glucose and Triglyceride Levels and Reduces Type 2 Diabetes Risk in the DESIR Prospective General French PopulationDiabetes, 2008
- Elimination of KATP Channels in Mouse Islets Results in Elevated [U-13C]Glucose Metabolism, Glutaminolysis, and Pyruvate Cycling but a Decreased γ-Aminobutyric Acid ShuntJournal of Biological Chemistry, 2008
- Glucokinase and IRS-2 are required for compensatory cell hyperplasia in response to high-fat diet-induced insulin resistanceJCI Insight, 2007
- Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker ratsBritish Journal of Pharmacology, 2006
- Conformational transition pathway in the allosteric process of human glucokinaseProceedings of the National Academy of Sciences of the United States of America, 2006
- Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmonyJCI Insight, 2006